Skip to main content
Clinical Trials/NCT03487003
NCT03487003
Completed
Not Applicable

Comparison of the Clinical Performances of Flexible Laryngeal Mask Airway in Pediatric Patients Under General Anesthesia With or Without Muscle Relaxant: a Randomized Controlled Non-inferiority Trial

Daegu Catholic University Medical Center1 site in 1 country128 target enrollmentApril 20, 2018

Overview

Phase
Not Applicable
Intervention
rocuronium
Conditions
Anesthesia Intubation Complication
Sponsor
Daegu Catholic University Medical Center
Enrollment
128
Locations
1
Primary Endpoint
Oropharyngeal leak pressure (OLP)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The use of laryngeal mask airway (LMA) is increasing in pediatric anesthesia because it provides lesser direct mechanical stimulation of the airway due to being placed above the larynx. However, LMA insertion can be more difficult in children than in adults due to their unique characteristics of pediatric airway. Neuromuscular blocking agents, so-called, muscle relaxants have long been used to facilitate insertion of airway devices. But there are pros and cons for the efficacy of muscle relaxants in LMA insertion, and most studies were investigated in adults.

Registry
clinicaltrials.gov
Start Date
April 20, 2018
End Date
July 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Daegu Catholic University Medical Center
Responsible Party
Principal Investigator
Principal Investigator

Eugene Kim

Assistant professor

Daegu Catholic University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Children aged between 2 and 7 years of American Society of Anesthesiologists physical status (ASA PS) I or II who are planned to receive ophthalmic surgery under general anesthesia

Exclusion Criteria

  • Refusal of consent
  • Present URI or other respiratory symptoms
  • Oro or facial anomaly
  • Poor dental condition
  • who cannot open their mouth or limited mouth opening
  • when the tracheal intubation is definitely needed

Arms & Interventions

MR group

When the patients asleep, 0.3 mg/kg rocuronium is administered.

Intervention: rocuronium

NMR group

When the patients asleep, 0.3 mg/kg saline is administered.

Intervention: saline

Outcomes

Primary Outcomes

Oropharyngeal leak pressure (OLP)

Time Frame: During 1 min after successful LMA intubation

It was determined by the method describe by Lopez-Gil and colleagues. Briefly, it was measured by closing the expiratory valve of the circle system at a fixed gas flow of 3l/min, recording the airway pressure at which audible leak sound was heard.

Secondary Outcomes

  • Intubation time(During 5-10 min after inhalation of sevoflurane)
  • Ease of intubation/mask bagging(During 5-10 min after inhalation of sevoflurane)
  • Fiberoptic view of LMA(During 5min after successful LMA insertion)
  • Mean blood pressure(During 5-10 min after inhalation of sevoflurane)
  • Heart rate(During 5-10 min after inhalation of sevoflurane)
  • Watcha scale every 10 min from time to PACU admission to discharge(During 60 minutes after PACU admission)
  • FLACC score on initial, 10, 20, and 30 min(During 60 minutes after PACU admission)
  • Eye opening time(During 1 hour after operation)
  • Extubation time(During 1 hour after operation)
  • Peak inspiratory pressure before and after the surgery(During 4 hour after anesthetic inhalation)
  • Tidal volume ratio before and after the surgery(During 4 hour after anesthetic inhalation)
  • Respiratory adverse events(During 1 hour after operation)
  • Postoperative complications(During 1 hour after operation)

Study Sites (1)

Loading locations...

Similar Trials